Artivion Inc (FRA:CYL)
€ 26.75 0.1 (0.38%) Market Cap: 1.14 Bil Enterprise Value: 1.43 Bil PE Ratio: 0 PB Ratio: 3.89 GF Score: 74/100

Artivion Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 18, 2023 / 12:45PM GMT
Release Date Price: €12.2
Mike Matson
Needham & Company, LLC - Analyst

Good morning. Thanks for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson and I lead the medtech and diagnostics equity research team at Needham & Company. With me is Artivion's EVP, COO, and CFO, Ashley Lee. Instead of a standard presentation, we're going to do a Q&A session. If you do have any questions you would like to ask, you can submit them electronically through the Needham conference website or you can feel free to e-mail them to me at [email protected], and I'll do my best to fit them in.

So with that, we're going to get started with the questions unless, Ashley, you'd like to make any sort of an introductory comments?

Ashley Lee
Artivion, Inc. - EVP & CFO

No, I mean, the only thing that I'll say is as we enter into 2023, it's really the first time in four years where we're operating in an almost nearly normal environment. So we're very optimistic as -- about our business as we move into 2023.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot